A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome
NCT05419492
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
47
Enrollment
INDUSTRY
Sponsor class
Conditions
Dravet Syndrome
Interventions
DRUG:
ETX101
Sponsor
Encoded Therapeutics